Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Debt to Equity Over TimeNormalizing
Percentile Rank64
3Y CAGR-26.0%
5Y CAGR-2.5%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
-26.0%/yr
Annual compound
5Y CAGR
-2.5%/yr
Recent deceleration
Percentile
P64
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
3 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.07 | -15.4% |
| 2024 | 0.08 | -36.8% |
| 2023 | 0.13 | -24.1% |
| 2022 | 0.17 | +48.6% |
| 2021 | 0.12 | +46.2% |
| 2020 | 0.08 | +104.6% |
| 2019 | 0.04 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |